Structure Database (LMSD)
| LM_ID | Common Name | Systematic Name | Main Class | Sub Class | Mass | Formula |
|---|---|---|---|---|---|---|
| LMFA01030748 | 5,6,15-trihydroxy-7,9,13-Eicosatrien-11-ynoic acid | 5,6,15-trihydroxy-7,9,13-Eicosatrien-11-ynoic acid | Fatty Acids and Conjugates [FA01] | Unsaturated fatty acids [FA0103] | 350.21 | C20H30O5 |
| LMFA03010205 | 15-dehydro-prostaglandin I2 | 6,9S-epoxy-11R-hydroxy-15-oxo-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 350.21 | C20H30O5 |
| LMFA03010206 | 15-keto-PGD2 | 9S-hydroxy-11,15-dioxo-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 350.21 | C20H30O5 |
| LMFA03010030 | 15-keto-PGE2 | 9,15-dioxo-11R-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 350.21 | C20H30O5 |
| LMFA03010130 | 19-hydroxy-PGA2 | 9oxo-15S,19-dihydroxy-5Z,10Z,13E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 350.21 | C20H30O5 |
| LMFA03010132 | 19-hydroxy-PGB2 | 9-oxo-15S,19-dihydroxy-5Z,8(12),13E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 350.21 | C20H30O5 |
| LMFA03010166 | 19R-hydroxy-PGA2 | 9-oxo-15S,19R-dihydroxy-5Z,10Z,13E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 350.21 | C20H30O5 |
| LMFA03010167 | 19R-hydroxy-PGB2 | 9-oxo-15S,19R-dihydroxy-5Z,8(12),13E-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 350.21 | C20H30O5 |
| LMFA03010142 | PGD3 | 9S,15S-dihydroxy-11-oxo-5Z,13E,17Z-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 350.21 | C20H30O5 |
| LMFA03010135 | PGE3 | 9-oxo-11R,15S-dihydroxy-5Z,13E,17Z-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 350.21 | C20H30O5 |
| LMFA03010045 | PGI3 | 6,9S-epoxy-11R,15S-dihydroxy-15Z,13E,17Z-prostatrienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 350.21 | C20H30O5 |
| LMFA03010023 | PGK2 | 9,11-dioxo-15S-hydroxy-5Z,13E-prostadienoic acid | Eicosanoids [FA03] | Prostaglandins [FA0301] | 350.21 | C20H30O5 |
| LMFA03020049 | 12-Oxo-20-hydroxy-leukotriene B4 | (5R,6Z,8E,10E,14Z)-5,20-dihydroxy-12-oxoicosa-6,8,10,14-tetraenoic acid | Eicosanoids [FA03] | Leukotrienes [FA0302] | 350.21 | C20H30O5 |
| LMFA03020053 | 15-Epi-lipoxin B5 | (5R,6E,8Z,10E,12E,14R,15R,17Z)-5,14,15-trihydroxyicosa-6,8,10,12,17-pentaenoic acid | Eicosanoids [FA03] | Leukotrienes [FA0302] | 350.21 | C20H30O5 |
| LMFA03020064 | 20-oxo-leukotriene B4 | (5S,6Z,8E,10E,12R,14Z)-5,12-dihydroxy-20-oxoicosa-6,8,10,14-tetraenoic acid | Eicosanoids [FA03] | Leukotrienes [FA0302] | 350.21 | C20H30O5 |
| LMFA03030005 | TXA3 | 9S,11S-epoxy,15S-hydroxy-thromboxa-5Z,13E,17Z-trien-1-oic acid | Eicosanoids [FA03] | Thromboxanes [FA0303] | 350.21 | C20H30O5 |
| LMFA03040011 | 15-Oxo-lipoxin A4 | (5R,6R,7E,9E,11Z,13E)-5,6-dihydroxy-15-oxoicosa-7,9,11,13-tetraenoic acid | Eicosanoids [FA03] | Lipoxins [FA0304] | 350.21 | C20H30O5 |
| LMFA03040009 | 15-oxo-LXA4 | 15-oxo-5S,6R-dihydroxy-7E,9E,11Z,13E-eicosatetraenoic acid | Eicosanoids [FA03] | Lipoxins [FA0304] | 350.21 | C20H30O5 |
| LMFA03070042 | 5,6,18-triHEPE | 5,6,18-trihydroxy-7E,9E,11E,14Z,16Z-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 350.21 | C20H30O5 |
| LMFA03070034 | 5S-Hp-18R-HEPE | 5S-hydroperoxy-18R-hydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 350.21 | C20H30O5 |
| LMFA03070039 | 5S-Hp-18S-HEPE | 5S-hydroperoxy-18S-hydroxy-6E,8Z,11Z,14Z,16E-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 350.21 | C20H30O5 |
| LMFA03070041 | 6-trans-5,12,18-triHEPE | 5,12,18-trihydroxy-6E,8E,10E,14Z,16Z-eicosapentaenoic acid | Eicosanoids [FA03] | Hydroxy/hydroperoxyeicosapentaenoic acids [FA0307] | 350.21 | C20H30O5 |
| LMFA03110009 | 8-iso-15-keto-PGE2 | 9,15-dioxo-11R-hydroxy-5Z,13E-prostadienoic acid-cyclo[8S,12R] | Eicosanoids [FA03] | Isoprostanes [FA0311] | 350.21 | C20H30O5 |
| LMFA03140002 | 10,11-dihydro-12-oxo-Resolvin E1 | 12-oxo-5S,18S-dihydroxy-6Z,8E,14Z,16E-eicosatetraenoic acid | Eicosanoids [FA03] | - | 350.21 | C20H30O5 |
| LMFA03140009 | 18S-Resolvin E1 | 5S,12R,18S-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid | Eicosanoids [FA03] | - | 350.21 | C20H30O5 |
| LMFA03140003 | Resolvin E1 | 5S,12R,18R-trihydroxy-6Z,8E,10E,14Z,16E-eicosapentaenoic acid | Eicosanoids [FA03] | - | 350.21 | C20H30O5 |
Download LMSD record summary for FA 20:5;O3